【C.S Group】: Antcin A and Steroid Combination Shows Synergistic Potential in Preliminary Study
TAIPEI, March 14, 2025 /PRNewswire/ -- Cordyceps Sunshine Biotech Holdings Co., Ltd. 【 C.S Group 】, in
{fullname}
About author
You should write because you love the shape of stories and sentences and the creation of different words on a page.
View all posts
Related posts
---
【C.S】 Group Targets Global Pet Medication Market with Groundbreaking Taiwanofungus-Based New Drug
TAIPEI, Dec. 6, 2024 /PRNewswire/ -- Cordyceps Sunshine Biotech Holdings Co., Ltd. 【C.S 】 Group, Taiwan's
---
China Medical University and Healthcare System Pioneers AI-Driven Drug Discovery and Allogeneic CAR-T Therapy: A Groundbreaking Leap in Cancer Treatment
TAICHUNG, Feb. 5, 2025 /PRNewswire/ -- Healthcare Expo Taiwan is a professional-oriented exposition involving
---
ASG Announces the Completion of pre-IND meeting with FDA for Lead Drug Beta1, Receiving Encouraging Feedback
TAIPEI, Feb. 26, 2025 /PRNewswire/ -- Asia Scientific Global (ASG), a company specializing in the research
---
Kelun-Biotech's novel ADC drug SKB518 has been granted the clearance of IND from the United States Food and Drug Administration (FDA)
CHENGDU, China, April 21, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the
---
Hanmi Pharmaceutical and Beijing Hanmi Progress Clinical Trials of Co-developed BH3120 as a Next-Generation Cancer Immunotherapy
Hanmi unveils tiral in progress poster on BH3120 at the Society for Immunotherapy of Cancer (SITC) in the
